At the HealthTech X Digitisation of Pharma summit in London in February, pharmaphorum editor-in-chief Jonah Comstock grabbed Nigel Brokenshire, director of UK digital for Bayer, for a quick intervi
Roche is on course for a third indication for its fast-growing ophthalmic disease therapy Vabysmo, after a pair of phase 3 trials showed it was effective at improving eyes
